Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemoradiotherapy and Stem Cell Support in Relapsed/Refractory Hodgkin's Disease
NCT00004169Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Nov 1993
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide in Hodgkin lymphoma (HL), sponsored by Northwestern University. Started Nov 1993; status: completed.
02
Drugs
etoposide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00004169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004169.